Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

Bath emollients have ‘no benefit beyond standard eczema care for children’

Bath emollients have ‘no benefit beyond standard eczema care for children’

May 9 2018 A study has found no evidence of clinical benefit from including bath emollients in...

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29
  • Bath emollients have ‘no benefit beyond standard eczema care for children’

    Bath emollients have ‘no benefit beyond standard eczema care for children’

    Wednesday, 09 May 2018 15:28
  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pregnant1May 11 2016

Vitamin and mineral supplements (VMS) taken before a woman becomes pregnant or during early pregnancy may not prevent a woman experiencing miscarriage. However, there is evidence to show that “women receiving multivitamins plus iron and folic acid had reduced risk for stillbirth,” Cochrane researchers have concluded.

 

The researchers reviewed 40 randomised controlled trials involving over 276,000 women and more than 278,000 pregnancies. Suitable studies for inclusion were those looking at single or multiple vitamin supplementation during pregnancy and compared to placebo, other vitamins, no vitamins or other interventions. The researchers included studies where supplementation had commenced prior to the pregnancy, around conception and through the first 20 weeks of the pregnancy.

For vitamin C, alone or in combination, the researchers found no difference to the risk of miscarriage or stillbirth. There was a similar conclusion for vitamin A supplementation.

The researchers also found no difference in miscarriage rates between women receiving multivitamins plus iron and folic acid compared with iron and folate only groups. In addition: “There was no evidence of any difference in the risk of total foetal loss, early or late miscarriage, stillbirth or congenital malformations between women supplemented with folic acid with or without multivitamins and/or iron compared with no folic acid groups.”

However, “there was evidence of a decrease in the risk for stillbirth among women receiving multivitamins plus iron and folic acid compared iron and folate only groups,” said the researchers. They noted that foetal loss was lower in women taking multivitamins without folic acid, and multivitamins with or without vitamin A, but the trial data was limited to a single studies with small numbers of women.

The researchers commented that vitamin supplementation is often recommended to women planning to become pregnant and during the pregnancy. They wanted to look at the relationship between vitamin supplementation and early pregnancy outcomes “particularly since the causes of miscarriage are unknown and the nutritional status of a mother can affect her baby’s development.”

They concluded: “Taking any vitamin supplements prior to pregnancy or in early pregnancy does not prevent women experiencing miscarriage. However, evidence showed that women receiving multivitamins plus iron and folic acid had reduced risk for stillbirth. There is insufficient evidence to examine the effects of different combinations of vitamins on miscarriage and miscarriage-related outcomes.”

Links:

Cochrane Review summary

OO Balogun et al. ‘Vitamin supplementation for preventing miscarriage’. Cochrane Database of Systematic Reviews. Published online May 6

OTC News

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for “significant medical and therapeutic benefits” before a decision is made.
June 19 2018 A practice-based audit will seek to explore community pharmacy’s contribution in supporting girls and women of childbearing potential who need to take valproate medicines. Launched by...